Clinical Trials Browser

Neoplasm Metastasis, Neoplasms

NCT04901702 2026-02-09

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

Neoplasms, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Rhabdoid Tumor

NCT03837977 2024-12-30

NET02

Phase 2 Completed

58 enrolled

Endocrine

Neoplasms, Carcinoma, Neuroendocrine

NCT03665441 2022-10-18

Trybeca-1

Phase 3 Completed

512 enrolled 19 charts

Tumor-Agnostic

Neoplasms

NCT00062842 2020-03-04

Study of Irinotecan on a Weekly Schedule in Children

Phase 1 Completed

23 enrolled

Tumor-Agnostic

Neoplasms

NCT00364143 2019-07-05

Safety Study of IHL-305 (Irinotecan Liposome Injection) to Treat Advanced Solid Tumors

Phase 1 Completed

40 enrolled

Tumor-Agnostic

Neoplasms

NCT02640365 2017-01-31

DOUBLIRI

Phase 1 Completed

10 enrolled

Tumor-Agnostic

Neoplasms

NCT02785068 2017-01-11

Evaluation of MM-151 + Nal-IRI + 5-FU + Leucovorin in RAS/RAF Wild-type Metastatic Colorectal Cancer

Phase 1/2 Withdrawn

Gastrointestinal

Neoplasms, Colorectal Neoplasms

Clinical Trials

A Study of ASP3082 in Adults With Advanced Solid Tumors

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

NET02

Trybeca-1

Study of Irinotecan on a Weekly Schedule in Children

Safety Study of IHL-305 (Irinotecan Liposome Injection) to Treat Advanced Solid Tumors

DOUBLIRI

Evaluation of MM-151 + Nal-IRI + 5-FU + Leucovorin in RAS/RAF Wild-type Metastatic Colorectal Cancer